Metabonomics, an omic science in systems biology developed in 1990s, is the global qualitative and quantitative assessment of all the low relative molecular mass endogenous metabolites within an organism or cells. The conception, technology platform, technical route, data analysis and current application in tumor biomarker discovery of metabonomics are reviewed in this paper.